The Future of Multiple Myeloma Treatment

EP: 1.Unmet Needs In Multiple Myeloma Management

EP: 2.Evolving Goals in Multiple Myeloma Treatment

EP: 3.Multiple Myeloma Induction Challenges and Future Options

EP: 4.Optimizing Multiple Myeloma Treatment: Quadruplet Therapy

EP: 5.Real-World Insights: Multiple Myeloma Treatment Challenges

EP: 6.Navigating the Multiple Myeloma Treatment Landscape

EP: 7.Real-world Multiple Myeloma Treatment: Insights and Challenges

Now Viewing

EP: 8.The Future of Multiple Myeloma Treatment

EP: 9.ASH 2023: Multiple Myeloma's Shifting Landscape: Trials and Clinical Perspectives

EP: 10.Multiple Myeloma Frontline Horizon: Quads, Bispecifics, and Breakthroughs

This is a video synopsis/summary of a Peer Exchange featuring Joshua Richter, MD; Rafat Abonour, MD; Faith Davies, MD; and Amrita Krishnan, MD.

In this forward-looking discussion on the future of myeloma treatment, Abonour emphasizes the distinction between real-world data and real-world evidence, emphasizing the improvement in data quality over the years. Richter envisions a transformation where large registries, incorporating electronic medical records and patient-reported surveys, become essential for generating real-world evidence. Davies highlights the potential to study quality-of-life impacts and address data gaps, especially in rare subgroups and treatment sequencing. The conversation underscores the importance of educating colleagues on the scientific validity of real-world evidence and its potential to address critical questions in myeloma treatment.

Video synopsis is AI-generated and reviewed by AJMC^® editorial staff.